MDB insiders file Form 144 to sell 1,336 shares valued at $395,055

Rhea-AI Filing Summary

MongoDB, Inc. (MDB) Form 144 shows a proposed sale of 1,336 shares of common stock through Morgan Stanley Smith Barney LLC on or about 08/28/2025. The filing reports an aggregate market value of $395,055.20 and total shares outstanding of 81,356,893, implying the sale represents approximately 0.0016% of outstanding shares. The shares were acquired on 10/01/2009 as a venture capital investment from the issuer and were paid for in cash. The filer reports no securities sold in the past three months and includes the standard Rule 144 representation regarding material nonpublic information.

Insights

Securities/Equity Analyst

TL;DR: Small, routine insider sale disclosed; immaterial to market capitalization.

The proposed sale of 1,336 shares for $395,055 is a de minimis disposition relative to the reported 81.36 million shares outstanding (about 0.0016%). From an equity-analyst perspective, this transaction is unlikely to affect valuation metrics or trading dynamics. The filing includes acquisition details showing a long-held VC investment from 2009 and notes no sales in the prior three months, which supports the characterization of this as a routine liquidity event rather than an active divestiture program.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 content requirements but key filer identifiers appear absent.

The Form 144 provides required transactional details: broker, class, quantity, acquisition date and nature, and statement regarding material nonpublic information. However, the filing's header fields for filer identification (CIK/CCC and contact name/email) appear blank in the provided content. Complete filer identification is important for transparency and record matching; the absence of those fields in this extract reduces the traceability of the disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1336	395055.20	81356893	08/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2009	VC investment	Issuer			1336	10/01/2009	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MongoDB's (MDB) Form 144 report?

The filing reports a proposed sale of 1,336 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $395,055.20 and an approximate sale date of 08/28/2025.

When and how were the shares being sold acquired?

The shares were acquired on 10/01/2009 as a VC investment from the issuer, with payment noted as cash.

How material is the proposed sale relative to outstanding shares?

The filing lists 81,356,893 shares outstanding; 1,336 shares represent about 0.0016% of outstanding shares, indicating the sale is immaterial in size.

Did the filer report other sales in the past three months?

No. The filing section for securities sold during the past three months states "Nothing to Report".

Are there any concerns about disclosures in this extract?

The extract does not include the filer’s CIK/CCC or contact name/email, which are typically present for traceability; this absence is noted in the filing content provided.